Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Annie Layno-Moses

Pain Medicine New York, NY Medical Doctor

NPI 1255776449 CMS profile 1392412

588 Broadway Rm 710, Apt 1G, New York, NY 10012

Open in the dashboard

General payments

$28,883

359 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Annie Layno-Moses of New York, NY is reported in the CMS Open Payments database as having received $28,883 across 359 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $617 5
2024 General $1,788 16
2023 General $1,268 18
2022 General $4,608 41
2021 General $10,833 117
2020 General $4,439 93
2019 General $5,330 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Annie Layno-Moses
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Annie Layno-Moses were reported at $617. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Annie Layno-Moses Pain Medicine median Middle half National median
2019 $5,330 $409 $115–$1,311 $163
2020 $4,439 $214 $66–$666 $114
2021 $10,833 $299 $84–$899 $132
2022 $4,608 $335 $103–$1,149 $149
2023 $1,268 $376 $114–$1,228 $160
2024 $1,788 $387 $115–$1,173 $164
2025 $617 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $17,827 121 payments
  2. Abbott Laboratories $4,646 104 payments
  3. Boston Scientific Corporation $1,387 11 payments
  4. Medtronic, Inc. $1,237 19 payments
  5. Vertiflex, Inc. $1,063 11 payments
  6. IBSA Pharma Inc. $526 35 payments
  7. Stratus Medical, LLC $465 5 payments
  8. Painteq LLC $200 3 payments
  9. Biodelivery Sciences International, Inc. $196 6 payments
  10. RedHill Biopharma Inc. $169 8 payments
  11. Other $1,167 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,005 314 payments
  2. Consulting Fee $8,203 15 payments
  3. Travel and Lodging $4,614 28 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $1,063 2 payments
Products named General payments · program years 2019–2025
  1. Omnia $10,778 34 payments
  2. Senza Spinal Cord Stimulation System $6,290 76 payments
  3. Proclaim IPG $2,416 47 payments
  4. Proclaim Family of SCS IPGs $1,655 45 payments
  5. Superion ISS $1,063 11 payments
  6. INTELLIS ADAPTIVESTIM $817 9 payments
  7. Licart $526 35 payments
  8. Nimbus $465 5 payments
  9. Senza $387 6 payments
  10. General - Pain Management $339 2 payments
  11. Other $3,562 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

359 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record